544 related articles for article (PubMed ID: 11870075)
21. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
[TBL] [Abstract][Full Text] [Related]
22. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
23. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.
Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H
J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495
[TBL] [Abstract][Full Text] [Related]
24. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K
Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950
[TBL] [Abstract][Full Text] [Related]
25. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
26. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
27. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
28. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells.
Mizutani A; Sugiyama I; Kuno E; Matsunaga S; Tsukagoshi N
J Bone Miner Res; 2001 Nov; 16(11):2043-9. PubMed ID: 11697800
[TBL] [Abstract][Full Text] [Related]
30. Spatial and temporal pattern of expression of interstitial collagenase, stromelysin/transin, gelatinase A, and TIMP-1 during experimental gastric ulcer healing.
Calabrò A; Grappone C; Pellegrini G; Evangelista S; Tramontana M; Schuppan D; Herbst H; Milani S
Digestion; 2004; 70(2):127-38. PubMed ID: 15375341
[TBL] [Abstract][Full Text] [Related]
31. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
[TBL] [Abstract][Full Text] [Related]
33. Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells.
Deng R; Su Z; Hua X; Zhang Z; Li DQ; Pflugfelder SC
Mol Vis; 2014; 20():1243-52. PubMed ID: 25352733
[TBL] [Abstract][Full Text] [Related]
34. Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats.
Xu GF; Li PT; Wang XY; Jia X; Tian DL; Jiang LD; Yang JX
World J Gastroenterol; 2004 Dec; 10(24):3621-7. PubMed ID: 15534918
[TBL] [Abstract][Full Text] [Related]
35. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
[TBL] [Abstract][Full Text] [Related]
36. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct regression and recrudescence.
Leśniak-Walentyn A; Hrabia A
Cell Tissue Res; 2016 Nov; 366(2):443-454. PubMed ID: 27342592
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F(2alpha) and indomethacin.
Ulug U; Goldman S; Ben-Shlomo I; Shalev E
Mol Hum Reprod; 2001 Dec; 7(12):1187-93. PubMed ID: 11719597
[TBL] [Abstract][Full Text] [Related]
38. 8-Iso-prostaglandin f(2alpha) reduces trophoblast invasion and matrix metalloproteinase activity.
Staff AC; Ranheim T; Henriksen T; Halvorsen B
Hypertension; 2000 Jun; 35(6):1307-13. PubMed ID: 10856282
[TBL] [Abstract][Full Text] [Related]
39. Control of extracellular matrix remodelling within ovarian tissues: localization and regulation of gene expression of plasminogen activator inhibitor type-1 within the ovine corpus luteum.
Smith GW; Gentry PC; Bao B; Long DK; Roberts RM; Smith MF
J Reprod Fertil; 1997 May; 110(1):107-14. PubMed ID: 9227364
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.
Salmela MT; MacDonald TT; Black D; Irvine B; Zhuma T; Saarialho-Kere U; Pender SL
Gut; 2002 Oct; 51(4):540-7. PubMed ID: 12235077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
